Life-extending breast cancer drug Ibrance to be fully funded from April

A life-prolonging drug is being fully funded for New Zealanders with advanced (metastatic) breast cancer, saving patients thousands of dollars and ultimately giving them more time. 
On Thursday, Pharmac announced it was funding Ibrance (palbociclib) from Ap… [+3370 chars]Source